BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31127771)

  • 1. Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment.
    Wang X; Zhou W; Ye T; Lin X; Zhang J;
    J Alzheimers Dis; 2019; 69(4):1161-1169. PubMed ID: 31127771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoarthritis and APOE4 Interact to Influence Memory Decline in Non-Demented Older People.
    Zhou K; Wu P;
    J Alzheimers Dis; 2022; 89(1):79-86. PubMed ID: 35848022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
    Sakurai R; Montero-Odasso M
    J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
    J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
    Liew TM
    Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
    J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage of the temporal lobe and APOE status determine neural compensation in mild cognitive impairment.
    Prieto Del Val L; Cantero JL; Baena D; Atienza M
    Cortex; 2018 Apr; 101():136-153. PubMed ID: 29475078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
    An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
    Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia.
    Jannati A; Toro-Serey C; Gomes-Osman J; Banks R; Ciesla M; Showalter J; Bates D; Tobyne S; Pascual-Leone A
    Alzheimers Res Ther; 2024 Jan; 16(1):2. PubMed ID: 38167251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.
    Beydoun MA; Boueiz A; Abougergi MS; Kitner-Triolo MH; Beydoun HA; Resnick SM; O'Brien R; Zonderman AB
    Neurobiol Aging; 2012 Apr; 33(4):720-731.e4. PubMed ID: 20619505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    Caillaud M; Maltezos S; Hudon C; Mellah S; ; Belleville S
    J Alzheimers Dis; 2023; 94(3):1047-1056. PubMed ID: 37355896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
    Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG
    J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.
    Striepens N; Scheef L; Wind A; Meiberth D; Popp J; Spottke A; Kölsch H; Wagner M; Jessen F
    Psychol Med; 2011 Sep; 41(9):1997-2006. PubMed ID: 21284913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.